SYNLAB UK & Ireland:

SYNLAB Acquires Geneius.

Published: 3rd July 2017

SYNLAB, the leading provider of medical diagnostic services in Europe, announced the acquisition of Geneius.

This acquisition extends SYNLAB’s repertoire of food and specialist microbiology testing services in the UK, as well as complementing the range of specialist testing across the Group’s wider European lab business, deepening the expertise and customer offering.

Geneius is a science-led business that delivers solutions to provide total reassurance across the production and supply chain. Geneius is a market leader in investigative microbiology using bespoke DNA analysis and aims to be the first choice provider for quality led analytical testing in the food and beverage, biotechnology, chemical, environmental, cosmetic, healthcare and consumer products sectors.

As part of the deal, SYNLAB will continue to support growth of the laboratory, to expand the repertoire of services and leverage its wider expertise across Europe to expand commercial opportunities. The Geneius management team will continue to lead the business and will join the wider SYNLAB specialist food, drink and industrial testing leadership team in the UK.

Dr Stuart Quin, CEO of SYNLAB UK commented that: “The acquisition of Geneius Laboratories continues SYNLAB’s expansion into specialist diagnostic testing services in the UK, as well as enhancing our broader capabilities across Europe. Geneius will enable SYNLAB to deliver an exceptional repertoire of high-value, innovative molecular tests to a wider range of customers in the UK and beyond”.

For further details regarding the acquisition of Geneius Laboratories, please click here.

Latest SYNLAB UK & Ireland News
SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation

Published: 23rd August 2023 Science for Life, Health and Wellbeing SYNLAB, the medical diagnostics provider, has set out its ambition to become the UK’s leading …

Read More (about 'SYNLAB sets its Sights on Becoming the UK’s Leading Laboratory Diagnostics Organisation')
Modern Slavery & Human Trafficking Statement 2023

Published: 11th July 2023 INTRODUCTION This is SYNLAB UK and Ireland’s (SYNLAB UK&I) Modern Slavery and Human Trafficking Statement under Section 54 of the UK…

Read More (about 'Modern Slavery & Human Trafficking Statement 2023')
Exceptional talent honoured during SYNLAB awards programme

Published: 8th December 2022 SYNLAB’s 2022 Excellence Awards recognised individuals and teams from across its UK & Ireland services, who display outstanding service in their…

Read More (about 'Exceptional talent honoured during SYNLAB awards programme')
SYNLAB Primed to Help Steer NHS’s COVID Bounce Back

Published: 13th October 2022 SYNLAB is ready to play a key role in assisting the UK’s ongoing COVID recovery after securing membership of NHS England’s…

Read More (about 'SYNLAB Primed to Help Steer NHS’s COVID Bounce Back')
Landmark Day for Pathology Partnership with Launch of Synnovis Brand

Published: 4th October 2022 A pathology partnership performing 32 million tests a year has been relaunched as ‘Synnovis’ – officially heralding the start of a…

Read More (about 'Landmark Day for Pathology Partnership with Launch of Synnovis Brand')
Pathology laboratory becomes the first in the UK to support remote plate reading  

Published: 15th June 2022 A pathology laboratory is leading the way in speeding up access to patient care and treatment after becoming the first in…

Read More (about 'Pathology laboratory becomes the first in the UK to support remote plate reading  ')
SYNLAB ESG Roadmap and Framework

Published: 17th May 2022 Introduction SYNLAB UK&I is thrilled to publish its UK&I ESG Framework and Roadmap, which outlines out how we will achieve our…

Read More (about 'SYNLAB ESG Roadmap and Framework')
GENDER Pay Gap Report 2020-21

Published: 21st September 2021 A Message From Our CEO Whilst we are pleased at the improvement in our gender pay gap over the past four…

Read More (about 'GENDER Pay Gap Report 2020-21')
SYNLAB Goes Public

Published: 30th April 2021 We are proud to announce that SYNLAB is now listed on the Frankfurt Stock Exchange. This historical milestone is built on…

Read More (about 'SYNLAB Goes Public')